Yousif Capital Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $420K | Sell |
17,556
-49
| -0.3% | -$1.17K | ﹤0.01% | 1539 |
|
|
2025
Q1 | $437K | Sell |
17,605
-454
| -3% | -$11.3K | 0.01% | 1495 |
|
|
2024
Q4 | $340K | Sell |
18,059
-446
| -2% | -$8.4K | ﹤0.01% | 1636 |
|
|
2024
Q3 | $279K | Sell |
18,505
-435
| -2% | -$6.55K | ﹤0.01% | 1757 |
|
|
2024
Q2 | $542K | Sell |
18,940
-2,105
| -10% | -$60.2K | 0.01% | 1439 |
|
|
2024
Q1 | $615K | Sell |
21,045
-2,150
| -9% | -$62.8K | 0.01% | 1430 |
|
|
2023
Q4 | $783K | Sell |
23,195
-565
| -2% | -$19.1K | 0.01% | 1344 |
|
|
2023
Q3 | $729K | Sell |
23,760
-1,342
| -5% | -$41.2K | 0.01% | 1299 |
|
|
2023
Q2 | $1.01M | Sell |
25,102
-1,578
| -6% | -$63.2K | 0.01% | 1157 |
|
|
2023
Q1 | $1.09M | Sell |
26,680
-3,375
| -11% | -$138K | 0.01% | 1107 |
|
|
2022
Q4 | $1.16M | Sell |
30,055
-6,995
| -19% | -$270K | 0.02% | 1088 |
|
|
2022
Q3 | $1.97M | Sell |
37,050
-309
| -0.8% | -$16.4K | 0.03% | 745 |
|
|
2022
Q2 | $2.18M | Sell |
37,359
-3,410
| -8% | -$199K | 0.03% | 759 |
|
|
2022
Q1 | $3.11M | Buy |
40,769
+865
| +2% | +$66K | 0.03% | 609 |
|
|
2021
Q4 | $2.4M | Buy |
+39,904
| New | +$2.4M | 0.02% | 846 |
|